Homology Medicines, Inc. (FIXX) Misses Q3 EPS by 14c

Homology Medicines, Inc. (NASDAQ: FIXX) reported Q3 EPS of ($0.57), $0.14 worse than the analyst estimate of ($0.43).

For earnings history and earnings-related data on Homology Medicines, Inc. (FIXX) click here.

You May Also Be Interested In

• AI and memory not a classic bubble, but future returns uncertain - strategist
• Darden Restaurants (DRI) Reports In-Line Q1 EPS, Misses on Revenue; Offers FY27 EPS Guidance
• Voya Financial warns shareholders about unsanctioned TCIM straw poll